Symposium on Hormones and the Kidney

Kidney International (1974) 6, 272–280; doi:10.1038/ki.1974.113

The adrenal cortex and the kidney

Frederic C Bartter1, Catherine S Delea1, Terukazu Kawasaki1 and John R Gill Jr1

1Hypertension—Endocrine Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland

Correspondence: Dr Frederic C Bartter, Hypertension-Endocrine Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014, U.S.A.

Top

Abstract

The adrenal cortex regulates renal function in a number of important ways; indeed, normal renal function cannot be understood without recognition of such regulation. Well-recognized examples of such regulation are the control of body fluid tonicity through regulation of urinary solute concentration-a function controlled "primarily" by vasopressin, but secondarily and importantly by the adrenal cortex-and control of body sodium-a function controlled primarily by renal tubular sodium reabsorption but regulated by sodium-retaining steroids.

The kidney can regulate adrenal function by changing reabsorption of sodium and secretion of potassium, and also by release of renin. The primary target of such regulation is the secretion of aldosterone, which may be influenced by body fluid volume, potassium ion and angiotensin II.

Because of these interrelationships, the pathophysiology of certain disease states may be described as aberrations in feedback loops between adrenal cortex and kidney. In this paper we will consider this "system" in some detail, and attempt to explain four disorders as examples of errors in control.

In the form of "primary" aldosteronism resulting from hyperplasia of all adrenal cortical tissue, overproduction of aldosterone persists in the absence of all known stimulatory factors. In renovascular hypertension, angiotensin and aldosterone production may persist despite systemic hypertension. In the non-salt-losing form of the adrenogenital syndrome of congenital adrenal hyperplasia without treatment, failure of feedback inhibition by Cortisol may result in overproduction of adrenocorticotropic hormone (ACTH) which, in turn, may lead to overproduction of progesterone. Progesterone may cause sodium loss and overproduction of renin and aldosterone while blocking their effects. In the syndrome of juxtaglomerular hyperplasia with normal blood pressure, overproduction of renin may result from unresponsiveness of blood vessels leading to a lack of feedback inhibition by pressure rise. Under certain circumstances sodium loss can potentiate both the overproduction and the unresponsiveness. Excessive renin leads to aldosteronism and potassium loss.

Top

References

  1. Bartter FC, Fourman P: The different effects of aldosterone-like steroids and hydrocortisone-like steroids on urinary excretion of potassium and acid. Metabolism 11:6, 1962
  2. Howell DS, Davis JO: Relationship of sodium retention to potassium excretion by the kidney during administration of desoxycorticosterone acetate to dogs. Am J Physiol 119:359, 1954
  3. Liddle GW, Pechet MM, Bartter FC: Enhancement of biological activities of corticosteroids by substitution of halogen atoms in 9 alpha position. Science 120:496, 1954
  4. Baniukiewicz S, Brodie A, Flood C, Motta M, Okamoto M, Tait JF, Tait SAS, Blair-West JR, Coghlan JP, Denton DA, Goding JR, Scoggins BA, Wintour M, Wright RD: Adrenal biosynthesis of steroids in vitro and in vivo using continuous superfusion and infusion procedures, in Functions of the Adrenal Cortex, edited by McKerns KW, New York, Appleton-Century-Crofts, 1968, vol. 1, pp. 153–232
  5. Landau RL, Lugibihl K: Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol 18:1237, 1958
  6. Garrod O, Davis SA, Cahill G Jr: The action of cortisone and desoxycorticosterone acetate on glomerular filtration rate and sodium and water exchange in the adrenalectomized dog. J Clin Invest 34:761, 1955
  7. Pechet MM, Bowers B, Bartter F: Metabolic studies with a new series of 1,4 diene steroids: I. Effects in Addisonian subjects of prednisone, prednisolone, and the 1,2 dehydro analogues of corticosterone, desoxycorticosterone, and 9 fluoro Cortisol. J Clin Invest 38:681–690, 1959
  8. Gill JR Jr, Gann DS, Bartter FC: Restoration of water diuresis in Addisonian patients by expansion of the volume of extracellular fluid. J Clin Invest 41:1078, 1962
  9. Kleeman CR, Maxwell MH, Rockney RE: Mechanisms of impaired water excretion in adrenal and pituitary insufficiency: I. The role of altered glomerular filtration rate and solute excretion. J Clin Invest 37:1799, 1958
  10. Gill JR Jr, Delea CS, Bartter FC: A role for sodiumretaining steroids in the regulation of proximal tubular sodium reabsorption in man. Clin Sci 42:423–432, 1972
  11. Wiederholt M, Stolte H, Brecht JP, Hierholzer K: Micropuncture research on the effect of aldosterone, cortisone and dexamethasone on renal sodium resorption in adrenalectomized rats. Arch ges Physiol 292:316–333, 1966
  12. Ullrich KJB, Marsh DJ: Kidney, water and electrolyte metabolism. Ann Rev Physiol 25:91–142, 1963
  13. Sonnenblick EH, Cannon PJ, Laragh JH: The nature of the action of intravenous aldosterone: Evidence for a role of the hormone in urinary dilution. J Clin Invest 40:903–913, 1961
  14. Giebish G: Functional organization of proximal and distal tubular electrolyte transport. Nephron 6:260–281, 1969
  15. Hilger H, Klumper J, Ullrich K: Wasserruckresorption und Ionentransport durch die Sammelrohrzellen der Saugetierniere. Arch ges Physiol 267:218–237, 1958 | Article | ChemPort |
  16. Berliner RW, Kennedy TJ Jr, Orloff J: Relationship between acidification of the urine and potassium metabolism. Am J Med 11:274–282, 1951 | Article | PubMed | ISI | ChemPort |
  17. Bartter FC: The mode of action of spironolactones and their use in the diagnosis of aldosteronism, in The Clinical Use of Aldosterone Antagonists. Springfield, Illinois, Charles C. Thomas, 1960
  18. Lindheimer MD, Ehrlich EN, Oparil S: Evidence for an effect of progesterone on proximal tubular Na+ reabsorption in man. Clin Res 20:763, 1972
  19. Meyer P, Menard J, Papanicolaou N, Alexandre JM, Devaux C, Milliez P: Mechanism of renin release following furosemide diuresis in rabbits. Am J Physiol 215:908, 1968
  20. Vander AJ, Carlson J: Mechanisms of the effects of furosemide on renin secretion in anesthetized dogs. Circ Res 25:145, 1969
  21. Brown JJ, Davis DL, Lever AF, Robertson JI: Influence of sodium deprivation and loading on the plasma renin in man. J Physiol (Lond) 173:408, 1964
  22. Brubacher ES, Vander AJ: Sodium deprivation and renin secretion in unanesthetized dogs. Am J Physiol 214:15, 1968
  23. Weinberger MH, Dowdy AJ, Nokes GW, Luetscher JA: Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretics. J Clin Endocrinol 28:359, 1968
  24. Vander AJ: Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209:659, 1965
  25. Michelakis AM, Caudle J, Liddle GW: In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP. Proc Soc Exp Biol Med 130:748, 1969 | PubMed | ChemPort |
  26. Winer N, Chokski DS, Walkenhorst WG: Effects of cyclic AMP, sympathomimetic amines and adrenergic receptor antagonists on renin secretion. Circ Res 29:239, 1971
  27. Veyrat R, Brunner HR, Manning EL, Muller AF: Inhibition de l'active de la renine plasmatique par le potassium. J Urol Nephrol (Paris) 73:271, 1967
  28. Vander AJ: Direct effects of potassium on renin secretion and renal function. Am J Physiol 219:455, 1970 | PubMed | ChemPort |
  29. Brunner HR, Baer L, Sealey JE, Ledingham JGG, Laragh JH: Influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 49:2128, 1970 | PubMed | ISI | ChemPort |
  30. Loeffler JR, Stockigt JR, Ganong WF: Effect of alpha-and beta-adrenergic blocking agents on the increase in renin secretion produced by stimulation of the renal nerves. Neuroendocrinology 10:129, 1972
  31. Johnson JA, Davis JO, Witty RT: Effects of catecholamines and renal nerve stimulation on renin release in the non-filtering kidney. Circ Res 29:646, 1971
  32. Coote JH, Johns EJ, Macleod VH, Singer B: Effect of renal nerve stimulation, renal blood flow and adrenergic blockade on plasma renin activity in the cat. J Physiol 226:15, 1972
  33. Privitera PJ, Mohammed S: Studies on the mechanism of renin suppression by alpha-methyldopa, in Control of Renin Secretion, edited by Assaykeen TA, New York, Plenum Press, 1972, p. 93
  34. Blaine EH, Davis JO, Witty RT: Renin release after hemorrhage and after suprarenal aortic constriction in dogs without sodium delivery to the macula densa. Circ Res 27:1081–1089, 1970
  35. Winer N, Walkenhorst WG, Helman R, Lamy D: Effects of adrenergic antagonists in states of increased renin secretion, in Control of Renin Secretion, edited by Assaykeen TS, New York, Plenum Press, 1972, p. 65
  36. Bunag RD, Vander AV, Kaneko Y, McCubbin JW: Control of renin release, in Renal Hypertension, edited by Page IH, McCubbin JW, Chicago, Year Book Medical Publishers, Inc., 1968, p. 100
  37. Tigerstadt R, Bergman PG: Niere und Kreislauf. Skand Arch Physiol 8:223, 1898
  38. Harris RC, Ayers CR: Renal hemodynamics and plasma renin activity after renal artery constriction on conscious dogs. Circ Res 31:520, 1972
  39. Boyd GW, Adamson AR, James VHT, Peart WS: The role of the renin-angiotensin system in the control of aldosterone in man. Proc R Soc Med 62:3–4, 1969
  40. Gann DS, Delea CS, Gill JR Jr, Thomas JP, Bartter FC: Control of aldosterone secretion by change of body potassium in normal man. Am J Physiol 207:104, 1964 | ISI | ChemPort |
  41. Burwell LR, Davis WW, Bartter FC: Studies on loci of action of stimuli to the biogenesis of aldosterone. Proc R Soc Med 62:4–7, 1969
  42. George JM, Wright L, Bell NH, Bartter FC: The syndrome of primary aldosteronism. Am J Med 48:343, 1970
  43. Davis WW, Newsome HH, Wright LD, Hammond WR, Easton J, Bartter FC: Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity. Am J Med 42:642, 1967
  44. Baer L, Brunner HR, Buhler FR, Laragh JH: Pseudoprimary aldosteronism, a variant of low-renin essential hypertension, in Hyptertension 1972, edited by Genest J, Koiw E, New York, Springer-Verlag, 1972, p. 459
  45. Brunner HR, Kirshman JD, Sealey JE, Laragh JH: Hypertension of renal origin: Evidence for two different mechanisms. Science 174:1344–1346, 1971
  46. Weiser RA, Johnson AG, Hoobler SW: The effect of antirenin on the blood pressure of the rat with experimental renal hypertension. Lab Invest 20:326–331, 1969
  47. Gross F: Adrenocortical function and renal pressor mechanisms in experimental hypertension, in Essential Hypertension, edited by Bock KD, Cottier PT, Berlin, Springer-Verlag, 1960, p. 92
  48. Pals DT, Masucci FD, Denning GS Jr, Sipos F, Fessler DC: Role of the presser action of angiotensin II in experimental hypertension. Circ Res 29:673–681, 1971 | PubMed | ISI | ChemPort |
  49. Davis WW, Burwell LR, Bartter FC: Inhibition of the effects of angiotensin II on adrenal steroid production by dietary sodium. Proc Natl Acad Sci USA 63:718–723, 1969
  50. Laragh JH, Sealey JE, Sommers SC: Patterns of adrenal secretion and urinary excretion of aldosterone and plasma renin activity in normal and hypertensive subjects. Circ Res 18 & 19 (suppl. 1):158–174, 1966
  51. Bartter FC, Henkin RI, Bryan GT: Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia. J Clin Invest 47:1742–1752, 1968
  52. Kowarski AJ, Finkelstein W, Spaulding JS, Holman GH, Migeon CJ: Aldosterone secretion rate in congenital adrenal hyperplasia. J Clin Invest 44:1505, 1965
  53. George JM, Saucier G, Bartter FC: Is there a potent, naturally occurring sodium-losing steroid hormone? J Clin Endocrinol 25:621, 1965
  54. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemia alkalosis: A new syndrome. Am J Med 33:811, 1962 | Article | PubMed | ISI | ChemPort |
  55. Cannon PJ, Leeming JM, Sommers SC, Winters RW, Laragh JH: Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): A reevaluation of the pathophysiology. Medicine 47:107, 1968
  56. Brunner HR, Chang P, Wallach R, Sealey JE, Laragh JH: Angiotensin II vascular receptors—their avidity in relationship to sodium balance, the autonomic nervous system and hypertension. J Clin Invest 51:58, 1972 | PubMed | ISI | ChemPort |
  57. Bryan GT, MacCardle RC, Bartter FC: Hyperaldosteronism, hyperplasia of the juxtaglomerular complex, normal blood pressure and dwarfism: Report of a case. Pediatrics 37:43, 1966
  58. Rubini ME: Water excretion in potassium-deficient man. J Clin Invest 40:2215–2224, 1961
  59. Bartter FC: The syndrome of juxtaglomerular hyperplasia. Birth Defects 10:104–108, 1974
  60. Chaimowitz C, Levi J, Better OS, Oslander L, Benderli A: Studies on the site of renal salt loss in a patient with Bartter's syndrome. Pediatr Res 7:89, 1973
  61. Chan JCM, Malekzadeh M, Anand S: Bartter's syndrome defect in renal tubular sodium reabsorption, in Clin Proc, Children's Hospital National Medical Center, in press
  62. Biava CG, Desjardins R, Bravo E, Bartter FC: Glomerular changes with glomerulo-distotubular shunts in patients with Bartter's syndrome. Lab Invest 20:575, 1969
  63. Thurau K: Influence of sodium concentration at macula densa cells on tubular sodium load. Ann NY Acad Sci 139–388, 1966

Extra navigation

.
ADVERTISEMENT